| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,824,000 | 2,312,000 | 2,442,000 | 2,161,000 | | Cost of Revenue | 2,560,000 | 630,000 | 1,624,000 | 2,866,000 | | | Gross Profit | 264,000 | 1,682,000 | 818,000 | (705,000) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (783,000) | 1,077,000 | 145,000 | (1,243,000) | | Non Recurring |
-
|
-
|
-
| (3,000) | | Others | 371,000 | 226,000 | 280,000 | 220,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 676,000 | 379,000 | 393,000 | 321,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 53,000 | 39,000 | 54,000 | 34,000 | | Earnings Before Interest And Taxes | 729,000 | 418,000 | 447,000 | 355,000 | | Interest Expense | 198,000 | 157,000 | 179,000 | 173,000 | | Income Before Tax | 531,000 | 261,000 | 268,000 | 182,000 | | Income Tax Expense | 181,000 | 86,000 | 85,000 | 66,000 | | Minority Interest | (2,000) |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 350,000 | 175,000 | 183,000 | 116,000 | | | Non-recurring Events | | Discontinued Operations | (102,000) | (1,000) |
-
| (9,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 246,000 | 174,000 | 183,000 | 107,000 | | Preferred Stock And Other Adjustments | 1,000 |
-
| (1,000) |
-
| | | Net Income Applicable To Common Shares | $247,000 | $174,000 | $182,000 | $107,000 |
|
0.01% Nasdaq 
0.22%
Income Statement
